Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access March 1, 2004

Heterocyclic inflammation inhibitors

Sham Sondhi, Shefali Rajvanshi, Nirupma Singh, Shubhi Jain and Anand Lahoti
From the journal Open Chemistry

Abstract

Non steroidal anti-inflammatory drugs are the most widely used medicines for relief of pain. These drugs have some side effects, particularly toxicity in the gastrointestinal tract and kidneys. Various approaches have been used for obtaining safer anti-inflammatory drugs. In this review we have summarized the recent developments in the following areas; (i) mode of action of NSAIDs (ii) Role of COX-1 & COX-2 in inflammation, (iii) Different approaches used to improve gastric tolerance i.e. chemical manipulation, formulation & co-administration, development of non specific (COX-1 & COX-2 inhibitors) and specific (COX-2 inhibitors) inflammation inhibitors, and development of inflammation inhibitors having a mode of action other than COX-1 & COX-2 inhibition. We have also focused on the safety of COX-2 inhibitors and the synthesis of heterocyclic compounds and their role as inflammation inhibitors.

[1] M.E. Wolff (Ed.): Burger’s Medicinal Chemistry. Part III, John Willy and sons, New York, 1981, pp. 1205–1271. Search in Google Scholar

[2] D. Ratnasinghe, P.J. Daschner, M.R. Anver, B.H. Kasprzak, P.R. Taylor, G.C. Yeh and J.A. Tangrea: “Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is Chemoprevention against multidrug resistance possible”, Anticancer Research, Vol. 21(3C), (2001), pp. 2141–2147. Search in Google Scholar

[3] W.A. Brown, S.A. Spinner, W.C. Malcontent, D. Vogiagis and P.E. O’Brien: “Non steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation”, Gut, Vol. 48(5), (2001), pp. 660–666. http://dx.doi.org/10.1136/gut.48.5.66010.1136/gut.48.5.660Search in Google Scholar

[4] J.A. Mitchell and T.D. Warner: “Cyclo-oxygenase-2, Pharmacology, physiology, biochemistry and relevance to NSAID therapy”, Br. J. Pharmacol., Vol. 128(6), (1999), pp. 1121–1132. http://dx.doi.org/10.1038/sj.bjp.070289710.1038/sj.bjp.0702897Search in Google Scholar

[5] G. Singh: “Recent consideration in non steroidal anti-inflammatory drug gastropathy”, Am. J. Med., Vol. 105(1B), (1998), pp. 31S-38S. http://dx.doi.org/10.1016/S0002-9343(98)00072-210.1016/S0002-9343(98)00072-2Search in Google Scholar

[6] L.A. Garc’aa Rodr’aguez: “Variability in risk of gastrointestinal complications with different non steroidal anti-inflammatory drugs”, Am. J. Med., Vol. 104, (1998), pp. 30S-34S. http://dx.doi.org/10.1016/S0002-9343(97)00208-810.1016/S0002-9343(97)00208-8Search in Google Scholar

[7] M. Schattenkirchner: “An updated safety profile of etodolac in several thousand patients”, Eur. J. Rheumatol. Inflamm., Vol. 10, (1990), pp. 56–65. Search in Google Scholar

[8] H.A. Friendel, H.D. Langtry and M.M. Buckley: “Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic disease”, Drugs, Vol. 45, (1993), pp. 131–156. Search in Google Scholar

[9] G.K. Mcevoy (Ed.): AHFS drug information, American society of hospital pharmacists Inc., Bethesda, 1992, pp. 1041–1126. Search in Google Scholar

[10] W.L. Xie et al.: “Expression of a nitrogen-responsive gene encoding prostaglandin synthase regulated by m-RNA splicing”, Proc. Natl. Acad. Sci. USA, Vol. 88(7), (1991), pp. 2692–2696. http://dx.doi.org/10.1073/pnas.88.7.269210.1073/pnas.88.7.2692Search in Google Scholar

[11] M. Feldman and A.T. McMahan: “Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?”, Ann. Intern Med., Vol. 132(2), (2000), pp. 134–143. Search in Google Scholar

[12] R.J. Flower: “Drugs which inhibit prostaglandin biosynthesis”, Pharmacol. Rev., Vol. 26(1), (1974), pp. 33–67. Search in Google Scholar

[13] C.J. Hawkey: “COX-2 inhibitors”, Lancet, Vol. 353, (1999), pp. 307–314. http://dx.doi.org/10.1016/S0140-6736(98)12154-210.1016/S0140-6736(98)12154-2Search in Google Scholar

[14] A. Bertolini, A. Ottani and M. Sandrini: “Selective COX-2 Inhibitors and dual acting anti-inflammatory drugs: Critical remarks”, Current Medicinal Chemistry, Vol. 9(10), (2002), pp. 1033–1043. http://dx.doi.org/10.2174/092986702460665010.2174/0929867024606650Search in Google Scholar

[15] L.S. Simon: “COX-2 inhibition. An advance or only pharmaceutical hype”, Arthritis care; Research, Vol. 45, (2001), pp. 209–215. http://dx.doi.org/10.1002/1529-0131(200106)45:3<209::AID-ART250>3.0.CO;2-A10.1002/1529-0131(200106)45:3<209::AID-ART250>3.0.CO;2-ASearch in Google Scholar

[16] J.A. Oviedo and M. Wolfe: “Clinical potential of cyclooxygenase-2 inhibitors”, Bio Drugs, Vol. 15, (2001), pp. 563–572. Search in Google Scholar

[17] V. Granados-Soto, R. Alonso-Lopez, R. Asomoza-Espinosa, M.O. Rufino, L.D. Gomes-Lopes and S.H. Ferrira: “Participation of COX, 1L-1β and TNFα in formalin-induced inflammatory pain”, Proceedings of the Western Pharmacology Society, Vol. 44, (2001), pp. 15–17. Search in Google Scholar

[18] R.V. Martinez, M. Reval, D. Irene, M.D. Campos, J.A. Terron, R.A.M. Dominguez and F.J. Lopez-Munoz: “Involvement of peripheral cyclooxygenase-1 and cyclooxygenase-2 in inflammatory pain”, Journal of Pharmacy and Pharmacology, Vol. 54, (2002), pp. 405–412. http://dx.doi.org/10.1211/002235702177847510.1211/0022357021778475Search in Google Scholar

[19] B. Nilsson, S. Friman and J. Svanvik: “Inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 regulates the microcirculation of the inflamed gall bladder”, Portland Press proceedings, Vol. 16, (2000), pp. 193; Chem. Abstr., Vol. 136, (2000), 277219z. Search in Google Scholar

[20] O.J. Igwe, J.N. Murray and A.S. Moolwaney: “Interleukin 1-induced cyclooxygenase and nitric oxide synthase gene expression in the rat dorsal root ganglia is modulated antioxidants”, Neuroscience (Oxford), Vol. 105, (2001), pp. 971–985. Search in Google Scholar

[21] T. Brzozowski, P.C. Konfurek, S.J. Konfurek, D. Schuppan, D. Drozdowicz, S. Kwiecien, J. Majka, T. Nakamura and E.G. Hahn: “Effect of local application of growth factors on gastric ulcer healing and mucosal expression of cyclooxygenase-1 and −2”, Digestion, Vol. 64, (2001), pp. 15–29. http://dx.doi.org/10.1159/00004883510.1159/000048835Search in Google Scholar

[22] C.G. Egan, J.C. Lockhart, W.R. Ferrell, S.M. Day and J.S. Mclean: “Pathophysiological basis of acute inflammatory hyperemia in the rat knee: roles of cyclo-oxygenase-1 and −2”, Journal of Physiology (Cambridge), Vol. 539, (2002), pp. 579–587. http://dx.doi.org/10.1113/jphysiol.2001.01347310.1113/jphysiol.2001.013473Search in Google Scholar

[23] J.L. Wallace, W. Mc Knight, B.K. Reuter, N. Vergnolle: “NSAID- induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2”, Gastroenterology, Vol. 119, (2000), pp. 706–714. http://dx.doi.org/10.1053/gast.2000.1651010.1053/gast.2000.16510Search in Google Scholar

[24] B.M. Peskar: “Roles of cyclooxygenase isoforms in gastric mucosal defense”, Journal of Physiology (Paris), Vol. 95, (2001), pp. 3–9. http://dx.doi.org/10.1016/S0928-4257(01)00003-110.1016/S0928-4257(01)00003-1Search in Google Scholar

[25] B.F. Mc Adam, I.A. Mardini, A. Habib, A. Burke, J.A. Lawson, S. Kapoor and G.A. Fitz Gerald: “Effect of regulated expression of human cyclooxygenase isoform on eicosanoid and isocicosanoid production in inflammation”, J. Clin. Invest., Vol. 105, (2000), pp. 1473–1482. http://dx.doi.org/10.1172/JCI952310.1172/JCI9523Search in Google Scholar

[26] A.S. Kalgutkar and L.J. Marnett: “Amide derivatives for antiangiogenic and/or antitumorigenic use”, Chem. Abstr., Vol. 133, (2000), 99537c. Search in Google Scholar

[27] A.S. Kalgutkar and L.J. Marnett: “Converting COX-inhibiting compounds to derivatives that are selective COX-2 inhibitors as non steroidal, anti-inflammatory drugs”, Chem. Abstr., Vol. 133, (2000), 99555j. Search in Google Scholar

[28] W.C. Black, C. Bayly, M. Belley, C.C. Chan, S. Charleson, D. Denis, J.Y. Gauthier, R. Gordon, D. Guay, S. Kargman, C.K. Lau, Y. Leblanc, J. Mancini, M. Ouellet, D. Percival, P. Roy, K. Skorey, P. Tagari, P. Vickers, E. Wong, L. Xu and P. Prasit: “From Indomethacin to a selective COX-2 inhibitors. Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors”, Bioorganic & Medicinal Chemistry Letters, Vol. 6, (1996), pp. 725–730. http://dx.doi.org/10.1016/0960-894X(96)00100-X10.1016/0960-894X(96)00100-XSearch in Google Scholar

[29] C. Rordorf, N. Kellett, S. Mair, S. Milosavljev, J. Branson and G. Scott: “Gastroduodenal tolerability of lumiracoxib vs placebo and naproxen: a pilot endoscopic study in healthy male subjects”, Alimentary Pharmacology and Therapeutics, Vol. 18, (2003), pp. 533–541. http://dx.doi.org/10.1046/j.1365-2036.2003.01691.x10.1046/j.1365-2036.2003.01691.xSearch in Google Scholar

[30] A.S. Taha, N. Hudson, C.J. Hawkey, A.J. Swannell, P.N. Trye, J. Cottrell, S.G. Mass, T.J. Simon, R.D. Sturrock and R.N. Russell: “Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs”, N. Engl. J. Med., Vol. 334, (1996), pp. 1435–1439. http://dx.doi.org/10.1056/NEJM19960530334220410.1056/NEJM199605303342204Search in Google Scholar

[31] G.K. Mcevoy (Ed.): AHFS drug information, American society of hospital pharmacists Inc., Bethesda, 1992, pp. 1759–1763. Search in Google Scholar

[32] J.E. Low: “Method of preventing ulcer formation caused by non steroidal anti-inflammatory drugs employing tetrazol-benzothiophene carboxamide compounds”, Chem. Abstr., Vol. 123, (1995), 102781f. Search in Google Scholar

[33] C.S. Lai and T.M. Wang: “Protected forms of a conjugate combination of non-steroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase 2 (COX-2) inhibitors and their therapeutic use”, Chem. Abstr., Vol. 136, (2002), 15235f. Search in Google Scholar

[34] S.A. Cooper: “Analgesic and anti-inflammatory compositions containing COX-2 inhibitors”, Chem. Abstr., Vol. 136, (2002), 42872t. Search in Google Scholar

[35] P.C. Isakson, G.D. Anderson and S.A. Gregory: “Treatment of inflammation and inflammation related disorders with a combination of COX-2 inhibitors and a 5-lipoxygenase inhibitor”, Chem. Abstr., Vol. 133, (2000), 321880n. Search in Google Scholar

[36] A.K. Tiwari and A. Mishra: “Synthesis and anti-inflammatory activities of N4, N5-di-substituted 3-methyl-1H-pyrazolo[3,4-c] pyridazines”, Bioorg. Med. Chem., Vol. 9, (2001), pp. 715–718. http://dx.doi.org/10.1016/S0968-0896(00)00285-610.1016/S0968-0896(00)00285-6Search in Google Scholar

[37] T. Niho, I. Yamamoto, H. Mochizuki, I. Kimura, A. Imai and T. Nakase: “Pyrazine and quinoxaline derivatives and their use as antiulcer agents”, Chem. Abstr., Vol. 124, (1996), 202307v. Search in Google Scholar

[38] M. Fujitake, N. Mikami, H. Kasukawa, Y. Suwabe and A. Ota: “Preparation of pyrazine derivatives as blood platelet aggregation inhibitors and anti-inflammatory agents”, Chem. Abstr., Vol. 115, (1991), 71654v. Search in Google Scholar

[39] T. Kaneko, R. Clark, N. Ohi, F. Ozaki, T. Kawahara, A. Kamada, K. Okano, H. Yokohama, K. Muramoto, T. Arai, M. Ohkuro, O. Takenaka and J. Sonoda: “Preparation of pyrazinobenzothiazine derivatives and analogs for the treatment of inflammation and autoimmune disease”, Chem. Abstr., Vol. 128, (1998), 204878p. Search in Google Scholar

[40] K. Abe, F. Tafusa, J. Namikawa and Y. Manabe: “Preparation of heterocyclylaminophenols as inflammation inhibitors”, Chem. Abstr., Vol. 113, (1990), 231408g. Search in Google Scholar

[41] T.A. Kelly and R.J. Sorcek: “Novel N-(pyridine-4-yl) nitrogen heterocyclic compounds useful in the treatment of inflammatory disease”, Chem. Abstr., Vol. 134, (2001), 131536n. Search in Google Scholar

[42] T. Sohda, H. Makino, A. Baba and T. Yamane: “Thienopyridine derivatives as anti-inflammatory and antiarthritis agents”, Chem. Abstr., Vol. 132, (2000), 49954x. Search in Google Scholar

[43] E.E. Knauss and P. Kumar: “Synthesis and anti-inflammatory activity of 5-(1,2-dihydropyridyl)2-tetrazoleacetic acids, esters and amides”, Eur. J. Med. Chem., Vol. 28, (1993), pp. 881–885. http://dx.doi.org/10.1016/0223-5234(93)90040-L10.1016/0223-5234(93)90040-LSearch in Google Scholar

[44] R.M. Weier, P.W. Collins, M.A. Stealey, T.A. Barta and R.M. Huff: “4,5-Substituted imidazolyl compounds for the treatment of inflammation”, Chem. Abstr., Vol. 125, (1996), 33647u. Search in Google Scholar

[45] I.K. Khanna, R.M. Weier, P.W. Collins, Y. Yu, X. Xu, R.M. Huff, R.A. Partis and F.J. Koszyk: “1,2-Substituted imidazolyl compounds for the treatment of inflammation”, Chem. Abstr., Vol. 125, (1996), 33646t. Search in Google Scholar

[46] H. Yamada, T. Sugai, N. Kinoshita, Y. Goto, T. Sawara, N. Sueda, M. Yanai and K. Yamada: “Benzimidazole derivatives as asthma inhibitors and compositions containing benzimidazole derivatives”, Chem. Abstr., Vol. 126, (1997), 282801f. Search in Google Scholar

[47] A.E. Braendstroem, P.L. Lindberg and G.E. Sunden: “Preparation of 2-(pyridine-2-yl methyl sulfinyl)-benziidazoles as gastric acid secretion inhibitors”, Chem. Abstr., Vol. 116, (1992), 174146f. Search in Google Scholar

[48] T. Saito, N. Kawabe, T. Tanaka, E. Oomori and Y. Morya: “Preparation of aminopyridine derivatives as inflammation inhibitors”, Chem. Abstr., Vol. 126, (1997). 89267h. Search in Google Scholar

[49] Y. Yoshikawa, H. Saito, Y. Ochi and K. Hatayama: “Preparation of 3-sulfonamidopyridine derivatives as anti-inflammatory antipyretic and antiallergy agents”, Chem. Abstr., Vol. 119, (1993), 117119n. Search in Google Scholar

[50] K. Yoshikawa, M. Hasegawa, M. Suzuki, Y. Shimazaki, M. Ohtani, S. Saito and M. Goi: “Preapartion of nitrosulfonamidopyridine derivatives as anti-inflammatory antipyretic and analgesic”, Chem. Abstr., Vol. 128, (1998), 61428d. Search in Google Scholar

[51] X. Collins, J.M. Robert, M. Duflos, G. Wielgosz, B.G. Le, C. Robin-Dubigenon, N. Grimaud, F. Lang and J.Y. Petit: “Synthesis of N-pyridinyl (methyl)-1,2-dihydro-4-hydroxy-2-oxoquinoline-3-carboxamides and analogs and their anti-inflammatory activity in mice and rats”, J. Pharm. Pharmacol., Vol. 53, (2001), pp. 417–423. http://dx.doi.org/10.1211/002235701177550510.1211/0022357011775505Search in Google Scholar PubMed

[52] D.J. Hogenkamp, P. Nguyen and B. Shao: “Preparation of aryl substituted pyridines, pyrimidines, pyrazines and triazines with anticonsulsant and sodium channel blocking activity”, Chem. Abstr., Vol. 135, (2001), 257270k. Search in Google Scholar

[53] Shibata and H. Sakatani: “Preparation of substituted pyrimidine derivatives as analgesics and anti-inflammatory agents”, Chem. Abstr., Vol. 122, (1995), 290883s. Search in Google Scholar

[54] S. Paul, M. Gupta and R. Gupta: “Environmentally desirable synthesis without the use of organic solvent: Synthesis of 6-aryl-2 [(carboxymethyl) thio]-5-cyanopyrimidin-4(3H) one”, Indian J. Heterocyclic Chem., Vol. 9, (2000), pp. 313–314. Search in Google Scholar

[55] N. Kinton, P. Meghani and S. Thom: “Preparation of pyrmidinediones and thioxypyrimidinones as P2-purinoceptor 7-transmembrane (TM) G-protein coupled receptor antagonists”, Chem. Abstr., Vol. 131, (1999), 19017f. Search in Google Scholar

[56] J.W. Lee, B.Y. Lee, C.S. Kim, S.K. Lee and S.J. Lee: “Preparation of novel pyrimidine derivatives as gastric acid secretion inhibitors”, Chem. Abstr.,Vol. 132, (2000), 347584h. Search in Google Scholar

[57] B.J. Benson, X. Chen, G.J. Cianciolo, J. Diaz, K.S. Ishaq, S.L. Morris-Natschke, R.J. Uhing and H. Wong: “Preparation of hydroxyalkyl ammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines”, Chem. Abstr., Vol. 124, (1996), 261623t. Search in Google Scholar

[58] G. Myakushkene, E. Udrenaite, P. Gaidyalis and P. Vainilavichyus: “Synthesis and anti-inflammatory activity of 4,6-diphenyl-2-pyrimidine carboxylic acid amides”, Pharm. Chem. J., Vol. 33, (1999), pp. 24–26. http://dx.doi.org/10.1007/BF0250841210.1007/BF02508412Search in Google Scholar

[59] P.J. Vainilavichyus, V. Yu. Syadyaryavichyute, P.G. Gaidyalis and L.F. Gumbaragite: “Synthesis and anti-inflammatory activity of 4-substituted-2-isopropylthiopyrimidines”, Khim-Farm. Zh., Vol. 27, (1993), pp. 17–19. Search in Google Scholar

[60] A. Ranise, O. Bruno, F. Bondavalli, S. Schenone, M. D’Amico, M. Falciani, W. Filippelli and F. Rossi: “5-Substituted-2,3-dihydro-6-mercapto-1,3-diphenyl-2-thioxo-4(3H)-pyrimidinones and their 6-(acylthio)derivatives with platelet antiaggregating anti-inflammatory, antiarrhythmic, antihyperlipidemic and other activities”, Farmaco, Vol. 49, (1994), pp. 551–558. Search in Google Scholar

[61] R.K. Sahu, A. Magan, B. Gupta, S.M. Sondhi, R.C. Srimal and G.K. Patnaik: “Reactions of 4-isothiocyanato-4-methyl-2-pentanone with amines having functional groups at β position and anti-inflammatory evaluation of resulting heterocyclic compounds”, Phosphorus, Sulfur and Silicon, Vol. 88, (1994), pp. 45–51. Search in Google Scholar

[62] S.M. Sondhi, R.P. Verma, N. Singhal, R. Shukla, R. Raghubir and M.P. Dubey: “Antiinflammatory and analgesic activity evaluation of some thiocarbamate thiourea, bisthiourea, acridine acridone and pyrimidine derivatives”, Indian Drugs, Vol. 36, (1999), pp. 50–54. Search in Google Scholar

[63] S.M. Sondhi, M. Johar, N. Singhal, S.G. Dastidar, R. Shukla and R. Raghubir: “Synthesis and anticancer, anti-inflammatory and analgesic activity evaluation of some sulpha drug and acridine derivatives”, Monatsh Chem., Vol. 131, (2000), pp. 511–520. http://dx.doi.org/10.1007/s00706005033210.1007/s007060050332Search in Google Scholar

[64] S.M. Sondhi, A. Magan, R.K. Sahu, V.K. Mahesh, R. Shukla and G.K. Patnaik: “Evaluation of some anti-inflammatory pyrimidobenzimidazoles synthesized via Noval Tin (II) Chloride-Hydrochloride acid assisted water addition and reduction of 4,4,6-trimethyl-1(2-nitroaryl)-1,4-dihydropyrimidine-2(3H)-thiones”, Synthesis, Vol. 11, (1994), pp.1175–1180. http://dx.doi.org/10.1055/s-1994-2566710.1055/s-1994-25667Search in Google Scholar

[65] S.M. Sondhi, V.K. Sharma, R.P. Verma, N. Singhal, R. Shukla, R. Raghubir and M.P. Dubey: “Synthesis, anti-inflammatory and analgesic activity evaluation of some mercaptopyrimidine and pyrimidobenzimidazole derivatives”, Synthesis, Vol. 5, (1999), pp. 878–884. http://dx.doi.org/10.1055/s-1999-347210.1055/s-1999-3472Search in Google Scholar

[66] S.M. Sondhi, R.P. Verma, N. Singhal, V.K. Sharma, R. Shukla and G.K. Patnaik: “Antiinflammatory and analgesic activity evaluation of heterocyclic compounds synthesized by the reaction of 4-isothiocyanato-4-methyl-2-pentanone with amines”, Phosphorus Sulphur & Silicon, Vol. 118, (1996), pp. 7–19. Search in Google Scholar

[67] S.M. Sondhi, M. Johar, S. Rajvanshi, S.G. Dastidar, R. Shukla, R. Raghubir and J.W. Lown: “Anticancer, anti-inflammatory and analgesic activity evaluation of heterocyclic compounds synthesized by the reaction of 4-isothiothiocyanato-4-methylpentan-2-one with substituted o-phenylenediamines, o-diaminopyridine and (un) substituted o-diaminopyrimidines”, Aust. J. Chem., Vol. 54, (2001), pp. 69–74. http://dx.doi.org/10.1071/CH0014110.1071/CH00141Search in Google Scholar

[68] S.M. Sondhi, N. Singhal, R.P. Verma, S.K. Arora, R. Shukla and R. Raghubir: “Synthesis and anti-inflammatory and anticancer activity evaluation of some condensed pyrimidines”, Monatsh Chem., Vol. 131, (2000), pp. 501–509. http://dx.doi.org/10.1007/s00706005033110.1007/s007060050331Search in Google Scholar

[69] S.M. Sondhi, M. Johar, R. Shukla, R. Raghubir, N. Bharti and A. Azam: “Synthesis, anti-inflammatory, analgesic and antiamoebic activity evaluation of some pyrimidobenzimidazole and pyrimidopyridoimidazole derivatives”, Aust. J. Chem., Vol. 54, (2001), pp. 461–467. http://dx.doi.org/10.1071/CH0105510.1071/CH01055Search in Google Scholar

[70] S.M. Sondhi, S. Rajvanshi, M. Johar, N. Bharti, A. Azam and A.K. Singh: “Antiinflammatory, analgesic and antiamoebic activity evaluation of pyrimido [1,6-a] benzimidazole derivatives synthesized by the reaction of ketoisothiocyanates with mono and diamines”, Eur. J. Med. Chem., Vol. 37, (2002), pp. 835–843. http://dx.doi.org/10.1016/S0223-5234(02)01403-410.1016/S0223-5234(02)01403-4Search in Google Scholar

[71] S.S. Bhagwat, C.H. Lee, R.J. Perner and Y.C. Gu: “Preparation of 6,7-disubstituted 4-aminopyrido [2,3-d] pyrimidines as adenosine kinase inhibitors”, Chem. Abstr., Vol. 135, (2001), P152822p. Search in Google Scholar

[72] A. Vidal, M.L. Ferrandiz, A. Ubeda, A. Acero-Alarcon, J. Sepulveda-Arques and M.J. Alcaraz: “Effect of imidazo [1,2-a] pyrimidine derivatives on leukocyte function”, Inflammation Res., Vol. 50, (2001), pp. 317–320. http://dx.doi.org/10.1007/PL0000025010.1007/PL00000250Search in Google Scholar

[73] S. Laneri, A. Sacchi, M. Gallitelli, F. Arena, E. Lurachi, E. Abignente, W. Filippelli and F. Rossi: “Research on heterocyclic compounds-Part XXXIX. 2-Methyl-imidazo [1,2-a] pyrimidine-3-caroboxylic derivatives:Synthesis and anti-inflammatory activity”, Eur. J. Med. Chem., Vol. 33, (1998), pp. 163–170. http://dx.doi.org/10.1016/S0223-5234(98)80005-610.1016/S0223-5234(98)80005-6Search in Google Scholar

[74] C.J. Shishoo, T. Ravikumar, K.S. Jain, I.S. Rathod, T.P. Gandhi, M.C. Satia: “Synthesis of novel 1,2-(un) substituted-3-amino-5-aryl-6-arylaminopyrazolo [3,4-d] pyrimidin-4(5H) ones and their biological activities”, Indian J. Chem. Sec. B., Vol 38, (1999), pp. 1075–1085. Search in Google Scholar

[75] M. Inoe, Y. Shoji, T. Okamura, K. Hashimoto, M. Obara and T. Yasuda: “Preparation of pyrazolo [1,5-a] pyrimidine derivatives as analgesics”, Chem. Abstr., Vol. 124, (1996), 317190u. Search in Google Scholar

[76] C.J. Shishoo, U.S. Pathak, I.S. Rathod, K.S. Jain, C.G. Nargund, A.D. Taranalli, H. Patel, V. Kumar and V.S. Shirsath: “Synthesis and pharmacological evaluation of some novel 5-aryl-6-arylamine-1-phenylpyrazolo [3,4-d] pyrimidin-4(5H)-ones as analgesic and anti-inflammatory agents”, Indian J. Chem. Sec. B., Vol. 38, (1999), pp. 684–695. Search in Google Scholar

[77] B. Tozkoparan, M. Ertan, B. Krebs, M. Laegs, P. Kelicen and R. Demirdamar: “Condensed heterocyclic compounds: Synthesis and anti-inflammatory activity of novel thiazolo [3,2-a] pyrimidines”, Arch. Pharm., Vol. 331, (1998), pp. 201–206. http://dx.doi.org/10.1002/(SICI)1521-4184(199806)331:6<201::AID-ARDP201>3.0.CO;2-T10.1002/(SICI)1521-4184(199806)331:6<201::AID-ARDP201>3.0.CO;2-TSearch in Google Scholar

[78] B. Tozkoparan, M. Ertan, P. Kelicen and R. Demirdamar: “Synthesis and antiinflammatory activity of some thiazolo [3,2-a] pyrimidines derivatives”, Farmaco, Vol. 54, (1999), pp. 588–593. http://dx.doi.org/10.1016/S0014-827X(99)00068-310.1016/S0014-827X(99)00068-3Search in Google Scholar

[79] S.S. Bhagwat, C.H. Lee, M.D. Cowart, J.A. Mckie, A.L. Grillot, A.O. Stewart, G.Z. Zheng and R.J. Perner: “Preparation of 5,7-disubstituted-4-aminopyrido [2,3-d] pyrimidines as adenosine kinase inhibitors”, Chem. Abstr., Vol. 132, (2000), 308351k. Search in Google Scholar

[80] P. Molina, E. Aller, A. Lorenzo, P. Lopez-Cremades, I.U.A. Rioja, M.C. Terencio and M.J. Alcaraz: “Solid phase synthesis and inhibitory effects of some pyrido [1,2-c] pyrimidine derivatives on leukocyte functions and experimental inflammation”, J. Med. Chem., Vol. 44, (2001), pp 1011–1014. http://dx.doi.org/10.1021/jm000997g10.1021/jm000997gSearch in Google Scholar

[81] S. Oomura, N. Takenawa and S. Kamya: “A pyrimidine derivative for treatment of inflammatory bowel diseases”, Chem. Abstr., Vol. 123, (1995), 965b. Search in Google Scholar

[82] E. Abignente, F. Arena, P. de Caprariis, E. Luraschi, A. Sacchi, E. Lampa, L. Berrino and D. Donnoli: “Research on heterocyclic compounds XXVIII. Imidazo [1,2-c] pyrimidines”, Farmaco, Vol. 46, (1991), pp. 1099–1110. Search in Google Scholar

[83] E. Abignente, A. Sacchi, S. Laneri, F. Rossi, M. D’Amico, L. Berrino, V. Calderaro and C. Parrillo: “Research on heterocyclic compounds XXVII. Synthesis and Cyclooxygenase-indipendent anti-inflammatory and analgesic activity of imidazo-[1,2-a] pyrimidine derivatives”, Eur. J. Med. Chem., Vol. 29, (1994), pp. 279–286. http://dx.doi.org/10.1016/0223-5234(94)90097-310.1016/0223-5234(94)90097-3Search in Google Scholar

[84] N.A. Santagati, A. Caruso, V.M.C. Cutuli and F. Caccamo: “Synthesis and pharmacological evaluation of thieno [2,3-d] pyrimidine-2,4-dione and 5H pyrimido [5,4]indole-2,4-dione derivatives”, Farmaco, Vol. 50 (1995), pp. 689–695. Search in Google Scholar

[85] G. Romeo, F. Russo, A. Caruso, V. Cutuli and M. Amico-Roxas: “Synthesis of new thieno [2,3-d] pyrimidine-2,4-[1H,3H]diones with analgesic and anti-inflammatory activities”, Arzneim-Forsch, Vol. 48, (1998), pp. 167–172. Search in Google Scholar

[86] D. Bozsing, P. Sohar, G. Gigler and G. Kovacs: “Synthesis and pharmaceutical study of new 3,4-dihydro-2H,6H-pyrimido [2,1-b] [1,3] thiazines”, Eur. J. Med. Chem., Vol. 31, (1996), pp. 663–668. http://dx.doi.org/10.1016/0223-5234(96)85874-010.1016/0223-5234(96)85874-0Search in Google Scholar

[87] J. Bantick, M. Perry and P. Thorne: “Preparation of pyrimidine fused compounds as antiallergic and anti-inflammatory agents”, Chem. Abstr., Vol. 128, (1998), 140714x. Search in Google Scholar

[88] A.N. Gaidukevich, G.P. Kazakov, A.A. Kravchenko, L.A. Porokhnyak, V.V. Pinchuk and D.L. Velikii: “Synthesis and biological activity of acridinyl-9-thioacetic acids and their derivatives”, Khim. Pharm. Zh., Vol. 21, (1987), pp. 1067–1070. Search in Google Scholar

[89] I.B. Taraporewala and J.M. Kauffman: “Synthesis and structure activity relationships of anti-inflammatory 9,10-dihydro-9-oxo-2-acridinealkanoic acids and 4-(2-carboxyphenyl)amino benzene alkanoic acids”, J. Pharm. Sci., Vol. 79, (1990), pp. 173–178. http://dx.doi.org/10.1002/jps.260079021910.1002/jps.2600790219Search in Google Scholar

[90] W.E. Bondinell, Y.A. Reader and T.W.F. Ku: “Substituted bisacridines and related compounds as CCR5 receptor ligands, anti-inflammatory agents and antiviral Agents”, Chem. Abstr., Vol. 129, (1998), 122582u. Search in Google Scholar

[91] S.M. Sondhi, N. Singhal, R.P. Verma, R. Raghubir, A.K. Goel and G. K. Patnaik: “Syntheis, anti-inflammatory and analgesic activity evaluation of some 2-(9-acridinylamino)pyridines and 2-(9-acridinylamino/imino)thiazolines”, Indian J. Chem. Sec. B., Vol. 36, (1997), pp. 620–624. Search in Google Scholar

[92] S.M. Sondhi, V.K. Sharma, N. Singhal, R.P. Verma, R. Shukla, R. Raghubir and M.P. Dubey: “Synthesis and anti-inflammatory activity evaluation of some acridinyl amino antipyrine, acridinyl amino anthraquinone, acridino thiourea and thiazolino thiourea derivatives”, Phosphorus, Sulphur and Silicon, Vol. 156, (2000), pp. 21–33. Search in Google Scholar

[93] S.M. Sondhi, M. Johar, R. Shukla, R. Raghubir and S.G. Dastidar: “Synthesis of sulphadrug acridine derivatives and their evaluation for anti-inflammatory, analgesic and anticancer activity”, Indian J. Chem. Sec. B., Vol. 41, (2002), 2659–2666. Search in Google Scholar

[94] S.M. Sondhi, A. Magan, V.K. Mahesh, R.C. Srimal and A.K. Goel: “Synthesis, isomer identification by 2D-NMR and anti-inflammatory evaluation of some 9H-imidazolo [1,2-a] benzimidazole and perhydroimidazolo [1,2-d], [1,2,4] dithiazepine derivatives”, Indian J. Chem., Vol. 33B, (1994), pp. 1144–1149. Search in Google Scholar

[95] L. Revesz: “Preparation of 2-substituted 4,5-diaryl imidazoloes as antiinflammatories and immunosuppressants”, Chem. Abstr., Vol. 130, (1999), 125072j. Search in Google Scholar

[96] L.K. Labanauskas, A.B. Brukstus, P.G. Gaidelis, V.A. Buchinskaite, E.B. Udrenaite and V.K. Dauksas: “Synthesis and anti-inflammatory activity of some new 1-acylderivatives of 5,6-diethoxy-2-(methylthio)benzimidazole”, Pharm. Chem. J., Vol. 34, (2000), pp. 353–355. http://dx.doi.org/10.1023/A:100521330654410.1023/A:1005213306544Search in Google Scholar

[97] J.F. Eggler: “Preparation of benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis”, Chem. Abstr., Vol. 124, (1996), 117304x. Search in Google Scholar

[98] T.A. Kelly and R.J. Sorcek: “Novel N-(pyridin-4-yl)nitrogen heterocyclic compounds useful in the treatment of inflammatory disease”, Chem. Abstr., Vol. 134, (2001), 131536n. Search in Google Scholar

[99] T. Sohda, H. Makino, A. Baba and T. Yamane: “Thienopyridine derivatives as anti-inflammatory and antiarthritis agents”, Chem. Abstr., Vol. 132, (2000), 49954x. Search in Google Scholar

[100] M. Kato, S. Nishida, H. Kita Sato, N. Sakata and S. Kawai: “Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes”, Journal of Pharmacy and Pharmacology, Vol. 53, (2001), pp. 1679–1685. http://dx.doi.org/10.1211/002235701177807010.1211/0022357011778070Search in Google Scholar

[101] Y. Hu and G. Cheng: “Establishment of screening models for selective cyclooxygenase-2 inhibitors”, Yaoxue Xuebao, Vol. 35, (2000), pp. 343–346. Search in Google Scholar

[102] P. Kay-Mugford, S.J. Bori, J. LaMarre and P. Conlon: “In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogs”, Am. J. Vet. Res., Vol. 61, (2000), pp. 802–810. http://dx.doi.org/10.2460/ajvr.2000.61.80210.2460/ajvr.2000.61.802Search in Google Scholar

[103] J.R. Vane and R.M. Botting: “Mechanism of action of anti-inflammatory drugs”, Int. J. Tissue React., Vol. 20, (1998), pp. 3–15. Search in Google Scholar

[104] Z. Sui and M. Wachter: “Aryl phenyl hydrazides as selective COX-2 inhibitors for the treatment of inflammation”, Chem. Abstr., Vol. 133, (2000), 38226f. Search in Google Scholar

[105] J. Berg, H. Fellier, T. Christoph, P. Kremminger, M. Hartman, H. Blaschke, F. Rovensky, R. Towart and D. Stimmeder: “Pharmacology of selective cyclooxygenase-1 inhibitor, HN—56249: a novel compounds exhibiting a marked preference for the human enzyme in intact cells”, Naunym-Schmiedeberg’s Arch. Pharmacol., Vol. 361, (2000), pp. 363–372. http://dx.doi.org/10.1007/s00210990019210.1007/s002109900192Search in Google Scholar

[106] M. Pal, K.R. Yeleswarapu, R. Ramanujam, P. Misra, P.K. Mamnoor and S.R. Casturi: “Preparation of 3,4-diphenyl-2,5-dihydro-2-furanones as novel compounds having anti-inflammatory activity”, Chem. Abstr., Vol. 136, (2000), 5893e. Search in Google Scholar

[107] C. Almansa, C. Gonzalez and M.C. Torres: “Novel imidazoles with anti-inflammatory activity and their preparation and use”, Chem. Abstr., 132, (2000), 308336j. Search in Google Scholar

[108] I.K. Khanna, Yi. Yu, R.M. Huff, R.M. Weier, X. Xu, F.J. Koszyk, P.W. Collins, J.N. Cogburn, P.C. Isakson, C.M. Koboldt, J.L. Masferrer, W.E. Perkins, K. Seibert, A.W. Veenhuizen, J. Yuan, D.C. Yang, Y.Y. Zhang: “Selective cyclooxygenase-2-inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active anti-inflammatory agents”, J. Med. Chem., Vol. 43, (2000), pp. 3168–3185. http://dx.doi.org/10.1021/jm000071910.1021/jm0000719Search in Google Scholar

[109] J.J. Talley, J.A. Sikorski, M.J. Graneto, J.S. Carter, B.H. Norma, B. Devadas and H.F. Lu: “Preparation of heterocycle substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors”, Chem. Abstr., Vol. 136, (2002), 69808p. Search in Google Scholar

[110] S. Barkey, L. Goossens, T. Taverne, J. Cornet, V. Choesmel, C. Rouand, G. Gimeno, S. Yannic-Arnoult, C. Michaux, C. Charlier, R. Houssin and J.-P. Henichart: “Synthesis and activity of a new Methoxytetra-hydropyran derivatives as duel cyclooxygenase-2/5-Lipoxygenase inhibitor”, Bioorganic & Medicinal Chemistry Letters, Vol. 12, (2002), pp. 779–782. http://dx.doi.org/10.1016/S0960-894X(02)00013-610.1016/S0960-894X(02)00013-6Search in Google Scholar

[111] M.J. Graneto, S.J. Hartman, S. Metz, M.J. Talley, M.L. Vazquez, D.L. Brown, R.M. Weier, M.A. Stealey and X. Xu: “Preparation of heteroarylpyrazoles using dithietanses”, Chem. Abstr., Vol. 133, (2000), 4657g. Search in Google Scholar

[112] M.R. Cuberes-Altisent, J.M. Berrocal-Romero, M.M. Contijoch-Llobet and J. Frigola-Constansa: “Diaryl pyrazoles as inhibitors of COX-2”, Chem. Abstr., Vol. 132, (2000), 12302g. Search in Google Scholar

[113] K. Ando, T. Kato, A. Kawai and T. Nonomura: “Preparation of heterocyclyl sulfonylbenzene compounds as anti-inflammatory/analgesic agents”, Chem. Abstr., Vol. 132, (2000), 35714g. Search in Google Scholar

[114] K. Ando, K. Kawamura, T. Kato, M.L. Minich, K.M. Lundy, H. Cheng, J. Li, B.S. Bronk, S.M. Sakya: “Synthesis and use of heteroaryl phenyl pyrazoles as anti-inflammatory/analgesic agents”, Chem. Abstr., Vol. 135, (2001), 19659z. Search in Google Scholar

[115] K. Ando and K. Kawamura: “Preparation of sulfamoyal hetero aryl pyrazole compound as anti-inflammatory and analgesic agents”, Chem. Abstr., Vol. 135, (2001), 33472q. Search in Google Scholar

[116] T. Ochi and T. Goto: “Antiinflammatory activity of a novel selective cyclooxygenase-2 inhibitor, FR 140423 on type II collagen-induced arthritis in Lewi’s rats”, Prostaglandins and other Lipid Mediators, Vol. 66, (2001), pp. 317–327. http://dx.doi.org/10.1016/S0090-6980(01)00171-X10.1016/S0090-6980(01)00171-XSearch in Google Scholar

[117] M.C. Carter, A. Naylor, M. Pass, J.J. Payne and N.A. Pegg: “Preparation of substituted pyrimidines as selective cyclooxygenase-2 inhibitors”, Chem. Abstr., Vol. 136, (2002), 216760x. Search in Google Scholar

[118] J. Ishida, H. Yamamoto, N. Konishi, M. Morita, K. Nakamura, S. Miyata, T. Ochi, Y. Morita, E. Yoshimi and K. Kuroda: “Preparation of 3-aryl pyridines as cyclooxygenase inhibitors”, Chem. Abstr., Vol. 137, (2002), 109211b. Search in Google Scholar

[119] R.M. Weier, L.F. Lee, R.A. Partis and F.J. Koszyk: “Preparation of 2,3-diarylpyridines as selective cyclooxygenase-2-inhibitors”, Chem. Abstr., Vol. 131, (1999), 73565w. Search in Google Scholar

[120] D. Dube, R. Fortin, R. Friesen, Z. Wang and J.X. Gauthier: “Preparation of substituted pyridines as as cyclooxygenase inhibitors”, Chem. Abstr., Vol. 128, (1998), 140614q. Search in Google Scholar

[121] C. Black, G. Hughes and Z. Wang: “Prepartion of pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors”, Chem. Abstr., Vol. 128, (1998), 13207j. Search in Google Scholar

[122] K.L. McLaren, D.B. Smith and J.L. Tracy: “Preparation of benzofuran-2-carbonitriles and benzothiophene-2-carbonitriles as anti-inflammatory agents”, Chem. Abstr., Vol. 137, (2002), 20293y. Search in Google Scholar

[123] H.S. Shin, M.S. Park and S.K. Kwon: “Anti-inflammatory evaluation and synthesis of benzothiazine derivatives as cycloxygenase-2-inhibitor”, Yakhak Hoechi, Vol. 44, (2000), pp. 272–278. Search in Google Scholar

[124] G.J. Dear and K. Gohil: “Preparation of pyrazolo [1,5-b] pyridazines as selective inhibitors of COX-2”, Chem. Abstr., Vol. 136, (2002), 340687t. Search in Google Scholar

[125] I.B. Campbell and A. Naylor: “Preparation of pyrazolopyridines as selective inhibitors of COX-2 inhibitors”, Chem. Abstr., Vol. 132, (2000), 321858a. Search in Google Scholar

[126] P.J. Beswick, I.B. Campbell and A. Naylor: “Preparation of cyclo oxygenase-2-inhibiting-2, 3-diphenylimidazo [1,2-a] pyridine anti inflammatories”, Chem. Abstr., Vol. 126, (1997), 8117j. Search in Google Scholar

[127] J.S. Carter, M.G. Obukowicz, B. Devadas, J.J. Talley, D.L. Brown, M.J. Graneto, S.R. Bertenshaw, D.J. Jr. Rogier, S.R. Nagarajan, C.E. Hanan, S.J. Hartmann, C.L. Ludwig, S. Metz and D.E. Korte: “Preparation of benzopyran carboxylates and quinoline carboxylates as selective cyclooxygenase-2-inhibitors”, Chem. Abstr., Vol. 133, (2000), 43440a. Search in Google Scholar

[128] M.N. Riera: “Selective anti-inflammatory inhibitors of 2-cyclo-oxygenase”, Cienc, Tecnol. Pharm., Vol. 9, (1999), pp. 157–164. Search in Google Scholar

[129] M.S. Borges, H.A. Capriles, F.F. Caballero and C.R. Perez: “Tolerability to new COX-2 inhibitors in NSAIDs-sensitive patients with cutaneous reactions”, Annals of Allergy, Asthma & Immunology, Vol. 87, (2001), pp. 201–204. http://dx.doi.org/10.1016/S1081-1206(10)62226-010.1016/S1081-1206(10)62226-0Search in Google Scholar

[130] C. Brideau, S.C. Van and C.C. Chan: “In vitro effects of cyclo oxygenase inhibitors in whole blood of horses, dogs and cats”, American Journal of Veterinary Research, Vol. 62, (2001), pp. 1755–1760. http://dx.doi.org/10.2460/ajvr.2001.62.175510.2460/ajvr.2001.62.1755Search in Google Scholar

[131] U. Mahadevan, E.V. Jr. Loftus, W.J. Tremaine and W.J. Sandborn: “Safety of selective cyclooxygenase-2-inhibitors in inflammatory bowel disease”, American Journal of Gasteroenterology, Vol. 97, (2002), pp. 910–917. http://dx.doi.org/10.1111/j.1572-0241.2002.05608.x10.1111/j.1572-0241.2002.05608.xSearch in Google Scholar

[132] I. Tegeder, J. Pfeilschiffer and G. Geisslinger: “Cyclooxygenase-independent actions of cyclooxygenase inhibitors”, FASEB Journal, Vol. 15, (2001), pp. 2057–2072. http://dx.doi.org/10.1096/fj.01-0390rev10.1096/fj.01-0390revSearch in Google Scholar

[133] G. Di Girolamo, A. Franchi, A.R. De Las Santos, M.L. Marti, M. Farina, D.G. Fernandez and A. Mortha: “Effect of nonsteroidal anti-inflammatory drugs on lipoxygenase and cyclooxygenase activities on human colon segments from patients with neoplasia”, Medicina (Buenas Aries, Argentina), Vol. 61(5/1), (2001), pp. 566–572. Search in Google Scholar

[134] Y. Wu, R. Chen, J. Chen, A. Zhang and X. Pan: “IL-10 downregulates expression of cyclooxygenase-2 and its mediated PGE2 production in human mesangial cells”, Mianyixue Zazhi, Vol. 17, (2001), pp. 421–424. Search in Google Scholar

[135] T. Sato, T.Taguchi, H. Nakano, T. Inoue and N. Kawasaki: “Preparation of 1,2-substituted benzimidazole derivatives as antiallergic agents”, Chem. Abstr., Vol. 133, (2000), 238002s. Search in Google Scholar

[136] M.J. Suto, M.E. Goldman, L.M. Gayo, L.J. Ransome-Fong, M.S.S. Palanki and R.W. Sullivan: “Preparation of pyrimidinecarboxamides and Pyrazine carboxamides for treating inflammatory conditions”, Chem. Abstr., Vol. 126, (1997), 264109g. Search in Google Scholar

[137] S. Yasufuka and A. Motonaga: “Preparation of imidazopyridine derivatives as inflammation inhibitors”, Chem. Abstr., Vol. 120, (1994), 164170c. Search in Google Scholar

[138] T. Komatsu, Y. Kawaharra, T. Fuji, M. Takano and N. Hara: “Preparation of N-pyridylmethoxybenzyl)-N-hydroxy ureas as lipoxygenase inhibitors and thromboxane synthetase inhibitors”, Chem. Abstr., Vol. 125, (1996), 247620d. Search in Google Scholar

[139] J. Varghese, R.R. Rydel and S. Michael: “Preparation of 4-benzyl-2-phenylpyrimidine phospholipase A2 inhibitors”, Chem. Abstr., Vol. 132, (2000), 347577h. Search in Google Scholar

[140] R. Austin, A. Baxter, R. Bonnett, F. Hunt, F. Kinchin and P. Willis: “Preparation of novel thiazolopyrimidines as modulators of chemokine receptor activity”, Chem. Abstr., Vol. 132, (2000), 166252c. Search in Google Scholar

[141] J.S. Skotnicki and S.C. Gilman: “Preparation of 1,2,3,4-tetrahydro acridines and analogs as inhibitors of interleukin I”, Chem. Abstr., Vol. 112, (1990), 118672e. Search in Google Scholar

[142] M. Wachter and S.A. Beers: “Preparation of 2-substituted imidazoles useful in the treatment of inflammatory diseases”, Chem. Abstr., Vol. 130, (1999), 139340g. Search in Google Scholar

[143] S.A. Beers, E. Malloy, M.P. Wachter and W. Wu: “Preparation of substituted imidazoles useful in the treatment of inflammatory diseases”, Chem. Abstr., Vol. 129, (1998), 330728y. Search in Google Scholar

[144] D.A. Willoghby, A.R. Moore, N. Colville and R. Paul: “COX-1, COX-2 and COX-3 and the future treatment of Chronic inflammatory disease”, Lancet, Vol. 355(9204), (2000), pp. 646–648. http://dx.doi.org/10.1016/S0140-6736(99)12031-210.1016/S0140-6736(99)12031-2Search in Google Scholar

Published Online: 2004-3-1
Published in Print: 2004-3-1

© 2004 Versita Warsaw

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Scroll Up Arrow